USFDA APPLICATION NUMBER - 207968 / DOSAGE - GRANULE;ORAL - 180MG
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
DEFERASIROX(UNII: V8G4MOF2V9) (DEFERASIROX - UNII:V8G4MOF2V9) | DEFERASIROX | 90mg | 180mg | 360mg |
Inactive Ingredients
Ingredient Name | Catalent Germany Schorndorf GmbH | Ascend Laboratories, LLC | Cipla USA Inc. |
---|---|---|---|
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||
CROSPOVIDONE(2S7830E561) | |||
HYDROGENATED CASTOR OIL(ZF94AP8MEY) | |||
LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |||
MAGNESIUM STEARATE(70097M6I30) | |||
MICROCRYSTALLINE CELLULOSE 101(7T9FYH5QMK) | |||
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||
POLOXAMER 188(LQA7B6G8JG) | |||
POVIDONE K30(U725QWY32X) | |||
SILICON DIOXIDE(ETJ7Z6XBU4) | |||
SODIUM HYDROXIDE(55X04QC32I) | |||
SODIUM STEARYL FUMARATE(7CV7WJK4UI) |
LOOKING FOR A SUPPLIER?